Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Noordzij

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Urological Research|October 22, 2004
The genetic make-up of renal cell tumorsM A Noordzij, G H Mickisch
Urological Research|January 1, 1995
Neuroendocrine cells in the normal, hyperplastic and neoplastic prostateM A Noordzij, G J van Steenbrugge, T H van der Kwast, et al.
International Journal of Cancer|September 30, 1999
Decreased expression of CD44 in metastatic prostate cancerM A Noordzij, G J van Steenbrugge, F H Schröder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomyM A Noordzij, G J van Steenbrugge, N S Verkaik, et al.
International Journal of Cancer|July 28, 1995
The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomyM A Noordzij, T H van der Kwast, G J van Steenbrugge, et al.
The Journal of Urology|October 23, 1997
The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patientsM A Noordzij, J F Bogdanowicz, C van Krimpen, et al.
The Journal of Urology|November 4, 2000
Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancerA N Vis, M A Noordzij, K Fitoz, et al.
The Journal of Pathology|May 17, 2002
Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancerA N Vis, B W G van Rhijn, M A Noordzij, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinomaG H Mickisch, M A Noordzij, A vd Gaast, et al.
The Prostate|September 1, 1995
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissuesM A Noordzij, T H van der Kwast, G J van Steenbrugge, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Urological Research|October 22, 2004
The genetic make-up of renal cell tumorsM A Noordzij, G H Mickisch
Urological Research|January 1, 1995
Neuroendocrine cells in the normal, hyperplastic and neoplastic prostateM A Noordzij, G J van Steenbrugge, T H van der Kwast, et al.
International Journal of Cancer|September 30, 1999
Decreased expression of CD44 in metastatic prostate cancerM A Noordzij, G J van Steenbrugge, F H Schröder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 1, 1997
The prognostic value of CD44 isoforms in prostate cancer patients treated by radical prostatectomyM A Noordzij, G J van Steenbrugge, N S Verkaik, et al.
International Journal of Cancer|July 28, 1995
The prognostic influence of neuroendocrine cells in prostate cancer: results of a long-term follow-up study with patients treated by radical prostatectomyM A Noordzij, T H van der Kwast, G J van Steenbrugge, et al.
The Journal of Urology|October 23, 1997
The prognostic value of pretreatment expression of androgen receptor and bcl-2 in hormonally treated prostate cancer patientsM A Noordzij, J F Bogdanowicz, C van Krimpen, et al.
The Journal of Urology|November 4, 2000
Prognostic value of cell cycle proteins p27(kip1) and MIB-1, and the cell adhesion protein CD44s in surgically treated patients with prostate cancerA N Vis, M A Noordzij, K Fitoz, et al.
The Journal of Pathology|May 17, 2002
Value of tissue markers p27(kip1), MIB-1, and CD44s for the pre-operative prediction of tumour features in screen-detected prostate cancerA N Vis, B W G van Rhijn, M A Noordzij, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1995
Dexverapamil to modulate vinblastine resistance in metastatic renal cell carcinomaG H Mickisch, M A Noordzij, A vd Gaast, et al.
The Prostate|September 1, 1995
Determination of Ki-67 defined growth fraction by monoclonal antibody MIB-1 in formalin-fixed, paraffin-embedded prostatic cancer tissuesM A Noordzij, T H van der Kwast, G J van Steenbrugge, et al.
Pageof 2